FindTrial
Sign In

Use of normal saline injection during thyroid surgery to preserve parathyroid gland function and reduce incidence of postoperative hypoparathyroidism

Use of sub capsular saline injection during thyroid surgery to preserve parathyroid function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040913
Enrollment
320
Registered
2022-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E892- Postprocedural hypoparathyroidism

Interventions

Intervention1: Subcapsular saline injection during total thyroidectomy: Thyroid is exposed and the superior pole is mobilised in standard manner. In the intervention arm, the false capsule is raised a

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted for a total thyroidectomy with or without a neck dissection

Exclusion criteria

Exclusion criteria: 1. Patients undergoing less than total thyroidectomy 2. Previous neck, thyroid and parathyroid surgeries 3. Concurrent parathyroid disease 4. Previous received ablative dose of I-131

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Subcapsular saline injection (SCASI) in reducing the rate of post-thyroidectomy hypocalcemia and hypoparathyroidism.Timepoint: Immediate postop day 1 and 6 months later—

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr Ranjith Cheriyan Philip

Christian Medical College, Vellore

abrahamdt@gmail.com9747629806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026